Omnicell (OMCL) Competitors $32.32 +0.06 (+0.19%) Closing price 04:00 PM EasternExtended Trading$31.75 -0.57 (-1.76%) As of 04:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock OMCL vs. MASI, AMN, WST, HSTM, MDRX, CRTX, HNGE, PRVA, INSP, and ENOVShould you be buying Omnicell stock or one of its competitors? The main competitors of Omnicell include Masimo (MASI), AMN Healthcare Services (AMN), West Pharmaceutical Services (WST), HealthStream (HSTM), Veradigm (MDRX), Cortexyme (CRTX), Hinge Health (HNGE), Privia Health Group (PRVA), Inspire Medical Systems (INSP), and Enovis (ENOV). Omnicell vs. Its Competitors Masimo AMN Healthcare Services West Pharmaceutical Services HealthStream Veradigm Cortexyme Hinge Health Privia Health Group Inspire Medical Systems Enovis Omnicell (NASDAQ:OMCL) and Masimo (NASDAQ:MASI) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, media sentiment, analyst recommendations, profitability, institutional ownership and earnings. Which has more risk & volatility, OMCL or MASI? Omnicell has a beta of 0.82, suggesting that its share price is 18% less volatile than the S&P 500. Comparatively, Masimo has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Is OMCL or MASI more profitable? Omnicell has a net margin of 2.01% compared to Masimo's net margin of -24.85%. Masimo's return on equity of 26.54% beat Omnicell's return on equity.Company Net Margins Return on Equity Return on Assets Omnicell2.01% 4.27% 2.44% Masimo -24.85%26.54%11.49% Do analysts prefer OMCL or MASI? Omnicell presently has a consensus price target of $46.71, indicating a potential upside of 44.54%. Masimo has a consensus price target of $194.60, indicating a potential upside of 36.08%. Given Omnicell's higher probable upside, analysts plainly believe Omnicell is more favorable than Masimo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Omnicell 0 Sell rating(s) 3 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.57Masimo 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 1 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, OMCL or MASI? Omnicell has higher earnings, but lower revenue than Masimo. Masimo is trading at a lower price-to-earnings ratio than Omnicell, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmnicell$1.11B1.33$12.53M$0.5064.64Masimo$2.09B3.71-$304.90M-$8.52-16.78 Do insiders & institutionals have more ownership in OMCL or MASI? 97.7% of Omnicell shares are held by institutional investors. Comparatively, 86.0% of Masimo shares are held by institutional investors. 2.5% of Omnicell shares are held by company insiders. Comparatively, 16.9% of Masimo shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Does the media favor OMCL or MASI? In the previous week, Masimo had 11 more articles in the media than Omnicell. MarketBeat recorded 21 mentions for Masimo and 10 mentions for Omnicell. Omnicell's average media sentiment score of 1.42 beat Masimo's score of 0.84 indicating that Omnicell is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Omnicell 7 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Masimo 11 Very Positive mention(s) 2 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryMasimo beats Omnicell on 10 of the 17 factors compared between the two stocks. Get Omnicell News Delivered to You Automatically Sign up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding OMCL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OMCL vs. The Competition Export to ExcelMetricOmnicellMEDICAL INFO SYS IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.48B$2.05B$5.69B$10.27BDividend YieldN/AN/A5.72%4.60%P/E Ratio64.6434.9275.8626.51Price / Sales1.339.86489.92165.32Price / Cash10.4058.5825.8129.89Price / Book1.2011.6912.846.32Net Income$12.53M-$63.67M$3.28B$270.51M7 Day Performance-1.37%-2.07%0.20%2.15%1 Month Performance1.99%1.93%4.59%6.35%1 Year Performance-27.97%35.18%68.31%25.48% Omnicell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OMCLOmnicell4.064 of 5 stars$32.32+0.2%$46.71+44.5%-25.3%$1.48B$1.11B64.643,670Positive NewsInsider TradeMASIMasimo4.7685 of 5 stars$148.79+1.1%$193.60+30.1%+29.2%$8.08B$2.09B-17.465,600AMNAMN Healthcare Services4.6274 of 5 stars$20.97+0.6%$28.25+34.7%-61.4%$799.06M$2.77B-2.702,968Short Interest ↓WSTWest Pharmaceutical Services4.9839 of 5 stars$253.30+1.0%$320.71+26.6%-14.3%$18.21B$2.89B37.9210,600News CoveragePositive NewsAnalyst ForecastHSTMHealthStream4.3354 of 5 stars$28.09-0.2%$31.00+10.4%+0.8%$834.10M$295.21M41.931,093Positive NewsMDRXVeradigm2.5733 of 5 stars$4.85-0.2%$13.00+168.0%-52.6%$525.09M$1.53B0.008,000CRTXCortexymeN/A$1.61+0.3%N/A+117.7%$48.54MN/A-0.5455HNGEHinge HealthN/A$56.40+2.4%$55.73-1.2%N/A$4.42BN/A0.001,514PRVAPrivia Health Group4.4116 of 5 stars$23.59+1.3%$28.58+21.2%+17.9%$2.90B$1.90B214.471,140Positive NewsINSPInspire Medical Systems4.8962 of 5 stars$83.51-3.4%$164.50+97.0%-60.3%$2.47B$802.80M48.271,246Positive NewsENOVEnovis4.0365 of 5 stars$31.39-2.3%$51.00+62.5%-25.4%$1.79B$2.11B-2.207,367Positive News Related Companies and Tools Related Companies Masimo Competitors AMN Healthcare Services Competitors West Pharmaceutical Services Competitors HealthStream Competitors Veradigm Competitors Cortexyme Competitors Hinge Health Competitors Privia Health Group Competitors Inspire Medical Systems Competitors Enovis Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:OMCL) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersFanatics Hit $31B-Is This Nasdaq Next?Fanatics built an empire by owning the fan experience-scaling to a $31B valuation. But the next wave isn't abo...i2i Marketing Group, LLC | SponsoredWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredFree: The Crypto Summit That Could Change Your LifeWall Street’s Crypto Playbook—Revealed at This Free Event If you want to understand what's really happening...Crypto 101 Media | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Omnicell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Omnicell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
